Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NINDS

Notch Activation Promotes Stem Cell Survival In Vitro And In Vivo

  • Read more about Notch Activation Promotes Stem Cell Survival In Vitro And In Vivo
US Application 60/715,935
Filed on 2005-09-08

Immunological Tolerization To E-selection Prevents The Brain Damage Associated With Vascular Cognitive Impairment

  • Read more about Immunological Tolerization To E-selection Prevents The Brain Damage Associated With Vascular Cognitive Impairment
US Application 60/712,359
Filed on 2005-08-30

Method for enhance recovery Of motor control via Vibro-tactile Stimulation To an affected system

  • Read more about Method for enhance recovery Of motor control via Vibro-tactile Stimulation To an affected system
US Application 60/695,424
Filed on 2005-07-01

Differential Expression of Molecules Associated with Vascular Disease Risk

  • Read more about Differential Expression of Molecules Associated with Vascular Disease Risk
US Application 60/691,730
Filed on 2005-06-17

METHODS AND COMPOSITIONS FOR INHIBITING CELL DEATH OR ENHANCING CELL PROLIFERATION

  • Read more about METHODS AND COMPOSITIONS FOR INHIBITING CELL DEATH OR ENHANCING CELL PROLIFERATION
US Application 60/715,722
Filed on 2005-09-09

Differential Expression of Molecules Associated with Vascular Disease Risk

  • Read more about Differential Expression of Molecules Associated with Vascular Disease Risk
US Application 60/687,515
Filed on 2005-06-03

Bone Marrow Stem-cell Transplantation Stimulates Hair Growth And Correct Deleterious Effects Of Immuno-suppression On Skin

  • Read more about Bone Marrow Stem-cell Transplantation Stimulates Hair Growth And Correct Deleterious Effects Of Immuno-suppression On Skin
US Application 60/663,456
Filed on 2005-03-18

Method For Inducing Apoptosis And Aneupoidy Regression In Cancer Cells

  • Read more about Method For Inducing Apoptosis And Aneupoidy Regression In Cancer Cells
US Application 60/458,146
Filed on 2003-03-27

Methods of Diagnosing and Treating VHL Associated and Sporadic Renal Cell Carcinoma, and Other VHL Associated and Sporadic Counterpart Tumors Which Co-Express EPO and the EPO Receptor

  • Read more about Methods of Diagnosing and Treating VHL Associated and Sporadic Renal Cell Carcinoma, and Other VHL Associated and Sporadic Counterpart Tumors Which Co-Express EPO and the EPO Receptor
US Application 60/611,616
Filed on 2004-09-20

Peptidic Compound Mixtures As Therapeutic Agents In CNS Autoimmunity

  • Read more about Peptidic Compound Mixtures As Therapeutic Agents In CNS Autoimmunity
US Application 60/541,397
Filed on 2004-02-02

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • …
  • Next page ››
  • Last page Last »
Subscribe to NINDS
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health